AQbD-enhanced green RP-UPLC-PDA methodology for quantification and forced degradation studies for omeprazole, amoxicillin, and rifabutin
Abstract The ternary combination like omeprazole (OMP), amoxicillin (AMX), and rifabutin (RFB) was approved by the FDA in November 2019 for combating Helicobacter pylori infections and ulcers caused by this infection. This study aims to develop and authenticate a robust and eco-friendly RP-UPLC tech...
        Saved in:
      
    
          | Main Authors: | S. P. Ashnah Baffinsha, Vijayageetha Ragupathi, Hemanth Kumar Chanduluru | 
|---|---|
| Format: | Article | 
| Language: | English | 
| Published: | BMC
    
        2024-11-01 | 
| Series: | BMC Chemistry | 
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13065-024-01337-6 | 
| Tags: | Add Tag 
      No Tags, Be the first to tag this record!
   | 
Similar Items
- 
                
                    Red, green, and blue model assessment and AQbD approach to HPTLC method for concomitant analysis of metformin, pioglitazone, and teneligliptin        
                          
 by: Pintu Prajapati, et al.
 Published: (2024-11-01)
- 
                
                    The Effect of Omeprazole on Urinary Magnesium Excretion in Children with Peptic Diseases        
                          
 by: Fatemeh Famouri, et al.
 Published: (2024-04-01)
- 
                
                    Experimental solubility of omeprazole in pure and ethanol-modified subcritical water        
                          
 by: Meysam Salehian, et al.
 Published: (2024-11-01)
- 
                
                    Segmental retinal arteritis in a case of presumed bilateral rifabutin-associated hypopyon uveitis        
                          
 by: Shefali Sood, et al.
 Published: (2024-12-01)
- 
                
                    A sustainable RP-HPLC method for simultaneously estimating aceclofenac, paracetamol, and serratiopeptidase with AQbD optimization        
                          
 by: Vineetha Rosireddy, et al.
 Published: (2024-12-01)
 
       